Full-Time

Director – Facilities Engineering

Updated on 11/15/2024

ProKidney

ProKidney

51-200 employees

Develops cell therapy for chronic kidney disease

Biotechnology
Healthcare

Senior, Expert

Winston-Salem, NC, USA

Category
Engineering Management
Systems Engineering Management
Requirements
  • BS in Engineering preferred
  • 10+ years of pharma (or regulated industry) experience with 8+ years in professional and technical staff management with accountability for objectives and subsequent evaluation.
  • 10+ years of experience in facilities, maintenance and/or engineering
  • Solid background in facilities and project management.
  • Strong leadership and communication skills.
  • Ability to adapt to changing priorities and resource challenges.
  • Organized and capable of providing concise, logical recommendations.
Responsibilities
  • Develop and maintain procedures for design, construction, and commissioning of projects.
  • Manage project planning, including cost estimates and contracts.
  • Direct personnel and contractors for equipment installation and modifications.
  • Serve as the subject matter expert on engineering systems.
  • Collaborate with departments like Manufacturing and Quality to identify improvement projects.
  • Secure approvals for project justifications and manage engineering activity schedules.
  • Ensure compliance with cGMP during construction and facilitate documentation processes.
  • Maintain as-built documentation for all facilities.
  • Provide troubleshooting support and oversee environmental compliance efforts.
  • Track and communicate performance metrics.
  • Supervise engineering staff, ensuring quality of work and training.
  • Stay updated on industry standards and trends.
  • Build relationships with design and construction partners.
  • Ensure the quality of work performed by external partners.
  • Manage equipment handover to the maintenance team.

ProKidney focuses on treating Chronic Kidney Disease (CKD) through a novel cell therapy called rilparencel. This therapy aims to preserve kidney function in patients with advanced CKD, potentially delaying or eliminating the need for dialysis, which is often the only option for these patients. ProKidney is currently in the late stages of clinical trials, with early data indicating that rilparencel could effectively maintain kidney function. Unlike many competitors, ProKidney specifically targets the CKD market, which affects over 35 million adults in the U.S., and aims to fill a critical gap in treatment options. The company's goal is to provide a groundbreaking alternative to dialysis, significantly improving the quality of life for CKD patients.

Company Stage

IPO

Total Funding

$559.3M

Headquarters

Winston-Salem, North Carolina

Founded

N/A

Growth & Insights
Headcount

6 month growth

22%

1 year growth

44%

2 year growth

101%
Simplify Jobs

Simplify's Take

What believers are saying

  • Successful $140 million public and direct offering boosts financial stability and supports ongoing R&D efforts.
  • The potential approval and commercialization of rilparencel could revolutionize CKD treatment and significantly improve patient quality of life.
  • Expansion plans, including a new facility in Greensboro, promise job creation and economic growth.

What critics are saying

  • The biotech sector's inherent volatility, as evidenced by ProKidney's significant stock price fluctuations, could impact financial stability.
  • Dependence on the successful approval and commercialization of rilparencel means any regulatory setbacks could severely affect the company's prospects.

What makes ProKidney unique

  • ProKidney is pioneering a novel cell therapy, rilparencel, specifically targeting CKD, unlike many competitors who focus on broader therapeutic areas.
  • Their focus on delaying or eliminating the need for dialysis offers a unique value proposition in the CKD treatment landscape.
  • ProKidney's late-stage clinical trials and promising early data position it as a frontrunner in CKD cell therapy innovation.

Help us improve and share your feedback! Did you find this helpful?